Compare DSP Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
DSP Healthcare Fund
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
3.0
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
2.02
2.09
NAV
₹49.45
₹47.50
Fund Started
12 Nov 2018
25 Jun 2018
Fund Size
₹3514.02 Cr
₹6624.58 Cr
Exit Load
Exit load of 0.50% if redeemed within 1 month.
Exit load of 1% if redeemed within 15 days.
1 Year
8.09%
5.43%
3 Year
19.38%
23.11%
5 Year
14.50%
15.81%
Equity
92.30%
96.05%
Cash
7.70%
3.95%
Top 10 Holdings
Cipla Ltd. | 8.35% |
Ipca Laboratories Ltd. | 8.21% |
Sun Pharmaceutical Industries Ltd. | 8.14% |
Illumina Inc. (USA) | 7.59% |
Sai Life Sciences Ltd. | 6.88% |
Gland Pharma Ltd. | 6.54% |
Globus Medical Inc | 5.72% |
Apollo Hospitals Enterprise Ltd. | 4.81% |
Cohance Lifesciences Ltd. | 4.13% |
Vijaya Diagnostic Centre Ltd. | 3.60% |
Sun Pharmaceutical Industries Ltd. | 12.20% |
Dr. Reddy's Laboratories Ltd. | 8.22% |
Mankind Pharma Ltd. | 6.98% |
Cipla Ltd. | 6.67% |
Alkem Laboratories Ltd. | 5.67% |
Divi's Laboratories Ltd. | 5.57% |
Cohance Lifesciences Ltd. | 4.31% |
Medplus Health Services Ltd. | 3.66% |
Max Healthcare Institute Ltd. | 3.10% |
Syngene International Ltd. | 2.89% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
12 Nov 2018
25 Jun 2018
